The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with Microsatellitosis.

Of note, however, there was a mild trend to prolonged DFS with HR of 0.46 and 0.7 for targeted therapy and immunotherapy, respectively ( p = 0.17–0.2).

also in 257 other papers